ES8404355A1 - "procedimiento para preparar 9-(1,3-dihidroxi-2-propoximetil)-guanina y sus sales farmaceuticamente aceptables". - Google Patents

"procedimiento para preparar 9-(1,3-dihidroxi-2-propoximetil)-guanina y sus sales farmaceuticamente aceptables".

Info

Publication number
ES8404355A1
ES8404355A1 ES512414A ES512414A ES8404355A1 ES 8404355 A1 ES8404355 A1 ES 8404355A1 ES 512414 A ES512414 A ES 512414A ES 512414 A ES512414 A ES 512414A ES 8404355 A1 ES8404355 A1 ES 8404355A1
Authority
ES
Spain
Prior art keywords
guanine
pharmaceutically acceptable
dihydroxy
prepare
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512414A
Other languages
English (en)
Spanish (es)
Other versions
ES512414A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23017790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8404355(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES512414A0 publication Critical patent/ES512414A0/es
Publication of ES8404355A1 publication Critical patent/ES8404355A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES512414A 1981-05-21 1982-05-20 "procedimiento para preparar 9-(1,3-dihidroxi-2-propoximetil)-guanina y sus sales farmaceuticamente aceptables". Expired ES8404355A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06267210 US4355032B2 (en) 1981-05-21 1981-05-21 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent

Publications (2)

Publication Number Publication Date
ES512414A0 ES512414A0 (es) 1984-05-01
ES8404355A1 true ES8404355A1 (es) 1984-05-01

Family

ID=23017790

Family Applications (7)

Application Number Title Priority Date Filing Date
ES512414A Expired ES8404355A1 (es) 1981-05-21 1982-05-20 "procedimiento para preparar 9-(1,3-dihidroxi-2-propoximetil)-guanina y sus sales farmaceuticamente aceptables".
ES520849A Granted ES520849A0 (es) 1981-05-21 1983-03-22 Procedimiento para preparar n2-acil-9-(1,3-dihidroxi-2-propoximetil)-guaninas y sus sales famaceuticamente aceptables.
ES524900A Granted ES524900A0 (es) 1981-05-21 1983-08-12 Procedimiento para preparar 9-(1,3-dihidroxi-2-propoximetil)-guanina y sus sales farmaceuticamente aceptables.
ES524899A Granted ES524899A0 (es) 1981-05-21 1983-08-12 Procedimiento para preparar 9-1 3 dihidroxi 2 propoximetil guanina y sales farmaceuticamente aceptable
ES529383A Expired ES8606869A1 (es) 1981-05-21 1984-02-01 Procedimiento para preparar 9-(1, 3-dihidroxi-2-propoximetil)-guanina y sus sales farmaceuticamente aceptables
ES529384A Expired ES8701496A1 (es) 1981-05-21 1984-02-01 Procedimiento para preparar una sal de 9-(1, 3-dihidroxi-2-propoximetil)-guanina farmaceuticamente aceptable
ES533821A Expired ES8505681A1 (es) 1981-05-21 1984-06-28 Procedimiento para preparar n2-acil-9-(1, 3-dihidroxi-2-propoximetil)-guaninas y sus sales farmaceuticamente aceptables

Family Applications After (6)

Application Number Title Priority Date Filing Date
ES520849A Granted ES520849A0 (es) 1981-05-21 1983-03-22 Procedimiento para preparar n2-acil-9-(1,3-dihidroxi-2-propoximetil)-guaninas y sus sales famaceuticamente aceptables.
ES524900A Granted ES524900A0 (es) 1981-05-21 1983-08-12 Procedimiento para preparar 9-(1,3-dihidroxi-2-propoximetil)-guanina y sus sales farmaceuticamente aceptables.
ES524899A Granted ES524899A0 (es) 1981-05-21 1983-08-12 Procedimiento para preparar 9-1 3 dihidroxi 2 propoximetil guanina y sales farmaceuticamente aceptable
ES529383A Expired ES8606869A1 (es) 1981-05-21 1984-02-01 Procedimiento para preparar 9-(1, 3-dihidroxi-2-propoximetil)-guanina y sus sales farmaceuticamente aceptables
ES529384A Expired ES8701496A1 (es) 1981-05-21 1984-02-01 Procedimiento para preparar una sal de 9-(1, 3-dihidroxi-2-propoximetil)-guanina farmaceuticamente aceptable
ES533821A Expired ES8505681A1 (es) 1981-05-21 1984-06-28 Procedimiento para preparar n2-acil-9-(1, 3-dihidroxi-2-propoximetil)-guaninas y sus sales farmaceuticamente aceptables

Country Status (33)

Country Link
US (1) US4355032B2 (cg-RX-API-DMAC10.html)
EP (1) EP0066208B1 (cg-RX-API-DMAC10.html)
JP (2) JPS57203086A (cg-RX-API-DMAC10.html)
KR (1) KR890004663B1 (cg-RX-API-DMAC10.html)
AR (1) AR244227A1 (cg-RX-API-DMAC10.html)
AT (1) ATE15899T1 (cg-RX-API-DMAC10.html)
AU (1) AU572086B2 (cg-RX-API-DMAC10.html)
BR (1) BR8202931A (cg-RX-API-DMAC10.html)
CA (3) CA1305139C (cg-RX-API-DMAC10.html)
CS (4) CS235044B2 (cg-RX-API-DMAC10.html)
DD (2) DD213218A5 (cg-RX-API-DMAC10.html)
DE (1) DE3266644D1 (cg-RX-API-DMAC10.html)
DK (2) DK150304C (cg-RX-API-DMAC10.html)
ES (7) ES8404355A1 (cg-RX-API-DMAC10.html)
FI (1) FI73682C (cg-RX-API-DMAC10.html)
GR (1) GR76459B (cg-RX-API-DMAC10.html)
HK (1) HK67088A (cg-RX-API-DMAC10.html)
HU (2) HU186514B (cg-RX-API-DMAC10.html)
IE (1) IE53731B1 (cg-RX-API-DMAC10.html)
IL (1) IL65836A (cg-RX-API-DMAC10.html)
IN (1) IN156469B (cg-RX-API-DMAC10.html)
LU (1) LU88334I2 (cg-RX-API-DMAC10.html)
MY (1) MY8700793A (cg-RX-API-DMAC10.html)
NL (2) NL930022I1 (cg-RX-API-DMAC10.html)
NO (2) NO161740C (cg-RX-API-DMAC10.html)
NZ (1) NZ200691A (cg-RX-API-DMAC10.html)
PH (1) PH17975A (cg-RX-API-DMAC10.html)
PL (4) PL136004B1 (cg-RX-API-DMAC10.html)
PT (1) PT74934B (cg-RX-API-DMAC10.html)
RO (2) RO84860B (cg-RX-API-DMAC10.html)
SG (1) SG81687G (cg-RX-API-DMAC10.html)
SU (1) SU1176841A3 (cg-RX-API-DMAC10.html)
ZA (1) ZA823532B (cg-RX-API-DMAC10.html)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4508898A (en) * 1980-09-16 1985-04-02 Ogilvie Kelvin K Antiviral triazine compounds
US4507305A (en) * 1981-05-21 1985-03-26 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
PL141281B1 (en) * 1981-08-11 1987-07-31 Wellcome Found Process for preparing derivatives of purine
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
IE830186L (en) * 1982-02-01 1983-08-01 Syntex Inc Purines
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
EP0138683A3 (en) * 1983-09-30 1988-01-20 Merck & Co. Inc. Purine derivatives, their application in anti-viral compositions
US4806642A (en) * 1984-10-05 1989-02-21 Warner-Lambert Company Purine derivatives
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
US4621140A (en) * 1984-02-23 1986-11-04 Syntex (U.S.A.) Inc. Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxymethyl)-purines and certain derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
EP0190123A1 (en) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Immunoregulatory and anti-viral compound
NZ214520A (en) * 1984-12-12 1989-08-29 Syntex Inc Alkoxymethyl ether and ester derivatives in the production of guanine derivatives
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4642346A (en) * 1985-06-24 1987-02-10 Syntex (U.S.A.) Inc. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
ATE123285T1 (de) * 1988-12-19 1995-06-15 Wellcome Found Antivirale pyrimidin- und purinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate.
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
DE69417748T2 (de) * 1993-06-23 1999-08-19 Merrell Pharmaceuticals Inc. Carbo-acyclische nukleosidderivate als antivirale und antineoplastische mittel
US5840891A (en) * 1994-07-28 1998-11-24 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
IN179493B (cg-RX-API-DMAC10.html) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
EP0806425B1 (en) * 1996-04-09 2001-08-29 Lupin Laboratories Limited An improved regiospecific process for synthesis of acyclic nucleosides
US5852208A (en) * 1996-08-30 1998-12-22 Dixie Chemical Company, Inc. Method of producing compounds containing acyloxyalkoxy groups from alcohols
CN1091445C (zh) * 1999-12-29 2002-09-25 湖北省医药工业研究院 抗病毒药物中间体、它们的制备及应用
EP1490090A4 (en) 2002-02-22 2006-09-20 New River Pharmaceuticals Inc SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
AU2003274410A1 (en) * 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Pharmaceutical compositions of ganciclovir
AU2003278420A1 (en) * 2002-10-31 2004-05-25 Ranbaxy Laboratories Limited Process for the preparation of ganciclovir
WO2004048380A1 (en) * 2002-11-22 2004-06-10 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir
KR20080032014A (ko) 2003-01-14 2008-04-11 길리애드 사이언시즈, 인코포레이티드 복합 항바이러스 치료를 위한 조성물 및 방법
ITMI20031202A1 (it) * 2003-06-13 2004-12-14 Lyogen Ltd Forma di cristallina del ganciclovir
CA2537132A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Amorphous valganciclovir hydrochloride
JP4746866B2 (ja) * 2004-11-19 2011-08-10 Ｔｃｍ株式会社 キャリッジ用ガタ抑制装置
TWI375560B (en) * 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
WO2009120358A1 (en) * 2008-03-27 2009-10-01 Nektar Therapeutics Oligomer-nitrogenous base conjugates
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
PA8855601A1 (es) 2008-12-23 2010-07-27 Forformidatos de nucleósidos
AU2009329872B2 (en) 2008-12-23 2016-07-07 Gilead Pharmasset Llc Synthesis of purine nucleosides
BRPI0922508A8 (pt) * 2008-12-23 2016-01-19 Pharmasset Inc Análogos de nucleosídeo
CN101851239B (zh) * 2009-04-03 2012-11-28 上海益威实业有限公司 一种更昔洛韦的回收方法
CA2794671C (en) 2010-03-31 2018-05-01 Gilead Pharmasset Llc Stereoselective synthesis of phosphorus containing actives
WO2012154698A2 (en) * 2011-05-06 2012-11-15 Mckenna Charles E Method to improve antiviral activity of nucleotide analogue drugs
CN102627643B (zh) * 2012-04-10 2014-01-08 常州康丽制药有限公司 更昔洛韦的精制方法
JP2015536940A (ja) 2012-10-29 2015-12-24 シプラ・リミテッド 抗ウイルス性ホスホネート類似体及びその製造方法
US9505775B2 (en) * 2012-11-03 2016-11-29 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
CN103059023B (zh) * 2012-12-31 2015-09-30 浙江车头制药股份有限公司 一种制备更昔洛韦晶型ⅱ的方法
US9486530B1 (en) 2013-08-30 2016-11-08 Exela Pharma Sciences, LLC Ganciclovir compositions and related methods
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN113476413B (zh) * 2021-08-09 2022-06-28 海南海灵化学制药有限公司 一种注射用更昔洛韦钠冻干粉的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
AU7938482A (en) * 1980-12-22 1982-07-20 Astra Lakemedel Aktiebolag Novel derivatives of guanine
PL141281B1 (en) * 1981-08-11 1987-07-31 Wellcome Found Process for preparing derivatives of purine

Also Published As

Publication number Publication date
IL65836A (en) 1991-04-15
ES8507549A1 (es) 1985-09-16
KR890004663B1 (ko) 1989-11-24
ES512414A0 (es) 1984-05-01
RO84860A (ro) 1984-09-29
ES8500276A1 (es) 1984-11-01
PL136637B1 (en) 1986-03-31
ES529384A0 (es) 1987-01-01
IE53731B1 (en) 1989-02-01
IN156469B (cg-RX-API-DMAC10.html) 1985-08-10
US4355032A (en) 1982-10-19
PL242101A1 (en) 1984-07-16
NO161740C (no) 1989-09-20
ES8601204A1 (es) 1985-11-16
SU1176841A3 (ru) 1985-08-30
IL65836A0 (en) 1982-08-31
ES533821A0 (es) 1985-06-16
PL242100A1 (en) 1984-04-24
EP0066208A1 (en) 1982-12-08
PL246770A1 (en) 1984-08-27
PT74934A (en) 1982-06-01
CS235044B2 (en) 1985-04-16
ATE15899T1 (de) 1985-10-15
ES520849A0 (es) 1984-11-01
AU8389282A (en) 1982-11-25
DK504183A (da) 1983-11-03
DK227782A (da) 1982-11-22
RO87387B (ro) 1985-08-31
NO821676L (no) 1982-11-22
BR8202931A (pt) 1983-05-03
NO1994005I1 (no) 1994-07-29
ES524900A0 (es) 1985-11-16
CS235018B2 (en) 1985-04-16
ES529383A0 (es) 1986-05-16
NL930139I1 (nl) 1993-11-01
RO87387A (ro) 1985-08-31
FI73682C (fi) 1987-11-09
PT74934B (en) 1984-05-08
NO161740B (no) 1989-06-12
FI821794A0 (fi) 1982-05-20
PL136004B1 (en) 1986-01-31
DD203052A5 (de) 1983-10-12
ZA823532B (en) 1983-03-30
DK150304C (da) 1988-01-04
ES8701496A1 (es) 1987-01-01
HU186514B (en) 1985-08-28
US4355032B2 (en) 1990-10-30
DK504183D0 (da) 1983-11-03
LU88334I2 (fr) 1994-09-09
HK67088A (en) 1988-09-02
CA1305141C (en) 1992-07-14
JPH0529399B2 (cg-RX-API-DMAC10.html) 1993-04-30
JPH046195B2 (cg-RX-API-DMAC10.html) 1992-02-05
SG81687G (en) 1989-07-07
DK149001B (da) 1985-12-16
MY8700793A (en) 1987-12-31
AR244227A1 (es) 1993-10-29
NL930139I2 (nl) 1997-07-01
DK150304B (da) 1987-02-02
EP0066208B1 (en) 1985-10-02
NZ200691A (en) 1986-11-12
PL136579B1 (en) 1986-02-28
JPH04217983A (ja) 1992-08-07
PH17975A (en) 1985-02-22
PL236521A1 (en) 1984-01-02
HU188000B (en) 1986-03-28
ES524899A0 (es) 1985-09-16
DE3266644D1 (en) 1985-11-07
FI73682B (fi) 1987-07-31
DK149001C (da) 1988-11-28
ES8505681A1 (es) 1985-06-16
IE821210L (en) 1982-11-21
RO84860B (ro) 1984-10-30
JPS57203086A (en) 1982-12-13
NL930022I1 (nl) 1993-05-03
KR830010112A (ko) 1983-12-26
AU572086B2 (en) 1988-05-05
CA1305139C (en) 1992-07-14
PL136332B1 (en) 1986-02-28
GR76459B (cg-RX-API-DMAC10.html) 1984-08-10
US4355032B1 (cg-RX-API-DMAC10.html) 1983-06-14
CA1305140C (en) 1992-07-14
ES8606869A1 (es) 1986-05-16
CS235043B2 (en) 1985-04-16
CS235042B2 (en) 1985-04-16
DD213218A5 (de) 1984-09-05

Similar Documents

Publication Publication Date Title
ES8404355A1 (es) "procedimiento para preparar 9-(1,3-dihidroxi-2-propoximetil)-guanina y sus sales farmaceuticamente aceptables".
ATE49195T1 (de) Herstellung von fibraten.
ES539658A0 (es) Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados
ES8405766A1 (es) Procedimiento para preparar derivados de fenil-1-piperidino-2-propanol
ES8407049A1 (es) Un procedimiento para la preparacion de compuestos biciclicos.
ES8801672A1 (es) Un procedimiento para preparar derivados de alanil-prolina.
ES482357A1 (es) Procedimiento para preparar compuestos prostanoides.
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
SE8900828D0 (sv) Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desamma
DK148183D0 (da) Fremgangsmade til fremstilling af imidazolylphenyl-tetrahydropyridaziner
JPS54160753A (en) Nail enamel
ES543785A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dietilaminoalcoxi sustituido y sus sales deadicion acidas y amonicas cuaternarias
ES8301200A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
DE3269309D1 (en) Pyrrolo(2,3-d)carbazole derivatives, preparation thereof and their therapeutical use
ES8307820A1 (es) Procedimiento para la obtencion de esteres del acido 7b-2-(2amino-4-tiazolil)-2-(sin)-metoxiiminoacetamido-3-cefem-4-carboxilico.
ES8304977A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
ES465537A1 (es) Un procedimiento para la preparacion de un alcohol-x-(3,4- dimetoxifenetilaminometil)-2-alcoxibencilico racemico u op- ticamente activo
KR840004422A (ko) 사이프로헵타딘-3-카복실산의 에스테르 및 관련 화합물의 제조방법
IT7927962A0 (it) Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico.
ES8703423A1 (es) Un procedimiento para producir un derivado de acido indola- cetico
EP0490224A3 (de) Salicylaldehyd- und Salicylsäurederivate sowie deren Schwefelanaloge, Verfahren und Zwischenprodukte zu ihrer Herstellung
ES2054234T3 (es) Un procedimiento para la preparacion de derivados indol.
ES8600759A1 (es) Procedimiento para preparar 2-(fenetil)-5-((3, 4-metilendioxi)- -hidroxibencil)-pirrolidina
ES8707260A1 (es) Procedimiento para preparar derivados de aminoacidos
JPS5225740A (en) Preparation of o-acyl-amidinophenols or acid addition salts thereof

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040228